Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience
Giancarlo Comi(University of Milan), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Angelo Ghezzi, Lucia Moiola(Vita-Salute San Raffaele University), L. La Mantia(University of Cagliari), Vittorio Martinelli(Vita-Salute San Raffaele University), Maria Giovanna Marrosu(University of Cagliari), María Trojano(University of Bari Aldo Moro), Maria Pia Amato(University of Florence), Paolo Gallo(University of Padua), Francesco Patti(University of Catania), Marco Capobianco(Ospedale San Luigi Gonzaga), Carlo Pozzilli(Sapienza University of Rome), Pietro Annovazzi(Vita-Salute San Raffaele University), N. Milani(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Cited by 88
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|959